Micromet: Collaboration, License Agreement With Bayer Schering Pharma

Micromet, Inc. announced the signing of an option, collaboration and license agreement with Bayer Schering Pharma AG, Germany, under which Bayer Schering Pharma has the exclusive option to obtain a license to one of Micromet’s preclinical BiTE antibodies against an undisclosed oncology target.
TradingMarkets